To direct local educational agencies that receive certain Federal funds to require students in grades 9 through 12 to receive an electrocardiogram and an echocardiogram prior to participating in an athletic contest for the first time, and for other purposes.
Summary
HR9218 is a newly introduced bill requiring cardiac screening for high school athletes, but it is in the earliest legislative stage—referred to committee with only one cosponsor. No funding is authorized, and no specific companies are directly affected until binding mandates are passed.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9218 is a new bill at the referral stage with low momentum and no funding authorization.
- 2.No specific companies or sectors see measurable near-term market impact from this procedural action.
- 3.Investors should not act on this legislation at this stage; monitor for committee hearings or bipartisan cosponsors.
Market Implications
This bill currently has no discernible market implications. The cardiac screening mandate, if ultimately passed, would increase demand for ECG and echocardiogram services, potentially benefiting diagnostic equipment manufacturers. However, at this procedural stage, the linkage is too speculative for any actionable position. Investors should disregard this bill until it advances beyond committee referral.
Full Analysis
On June 9, 2026, Representative Josh Gottheimer (D-NJ-5) introduced HR9218 in the House, a bill directing local educational agencies receiving certain federal funds to require electrocardiograms and echocardiograms for first-time high school athletic participants. The bill was immediately referred to the House Committee on Education and Workforce on the same day. With only one cosponsor and no committee markup scheduled, this bill is at a procedural stage with low legislative momentum.
The bill does not authorize or appropriate any federal funding—it imposes a condition on existing funding streams. There is no specific dollar amount attached. The money trail is indirect: school districts would need to absorb or find funding for screening costs, which could shift budgets toward diagnostic services, but no direct contract or grant mechanism is specified.
Structural winners and losers cannot be determined at this stage. Medical device manufacturers (e.g., GE HealthCare $GEHC, Philips, Siemens Healthineers) could benefit if mandates expanded screening volumes, but the bill is too early-stage and lacks binding language to support any near-term revenue impact. No tickers meet the confidence threshold for inclusion.
No real market data was provided for analysis. The competitive landscape in cardiac screening is broad, including both large imaging firms and smaller point-of-care diagnostics, but no causal chain links a specific company's revenue to this procedural action.
The legislative timeline is uncertain: the bill must pass committee, receive floor votes in both chambers, and be signed into law. Given the early stage and narrow sponsorship, passage is unlikely in this session unless significant bipartisan support emerges.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
Protecting Health Care and Lowering Costs Act of 2025
Executive Order: Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
Veterans SPORT Act
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $1.1B Department of Veterans Affairs Contract
Consolidated Appropriations Act, 2026
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.